Feedback / Questions
AV-001 - Vasomune Therap, AnGes MG
https://www.businesswire.com/news/home/20240528034965/en/Vasomune-Therapeutics-Receives-US-FDA-Fast-Track-Designation-for-Novel-Investigational-Medicine-AV-001
May 28, 2024
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next